scription-polymerase chain reaction showed further expression in human trabecular meshwork (HTM), nonpigmented ciliary epithelium (NPCE), retina, brain, adrenal cortex, liver, fetus, lymphocyte, and fibroblast. Northern blotting revealed a major 2.0-kb transcript in HTM and NPCE and a minor 3.6-kb message that was three to four times less abundant ( Fig. 2A) .
Two different 18 -amino acid peptides from the NH 2 -and COOH-termini of optineurin were used to immunize chickens and to obtain antibodies to optineurin (18) . The selected peptides are 100% conserved within human, mouse, and macaque. One of these antibodies cross reacted (18) with an ϳ66-kD protein in whole-cell extracts from a variety of cell lines (Fig. 2B) . We also detected optineurin expression in aqueous humor samples of human, macaque, bovine, pig, goat, sheep, cat, and rabbit, suggesting that it is a secreted protein.
We next investigated the intracellular localization of optineurin by immunocytochemistry (18) using both primary and transformed cell lines. Endogenous optineurin showed granular staining that was associated with vesicular structures near the nucleus (Fig. 3 , A to C, E, and H). The staining colocalized (Fig. 3 , F and I) with a marker specific for the Golgi apparatus (Fig. 3, D and G) . In a dermal fibroblast culture from a patient with an E50K mutation, optineurin was present at much lower levels than in a similar culture from a normal subject.
Optineurin has no significant homology to any protein, but it is known to interact with adenovirus E3-14.7K (12), Huntingtin (15), transcription factor IIIA (16), RAB8 (17) , and two unknown kinases (14) . Optineurin's ability to block the protective effect of E3-14.7K on tumor necrosis factor-␣ (TNF-␣)-mediated cell killing suggests that this protein may be a component of the TNF-␣ signaling pathway that can shift the equilibrium toward induction of apoptosis (12) . TNF-␣ can markedly increase the severity of damage in optic nerve heads of both POAG and LTG subjects (20, 21) . We speculate that wild-type optineurin, operating through the TNF-␣ pathway, plays a neuroprotective role in the eye and optic nerve, but when defective, it produces visual loss and optic neuropathy as typically seen in normal and high-pressure glaucoma.
Identification of OPTN as an adult-onset glaucoma gene provides an opportunity to study the biochemical pathways that may be involved in the pathogenesis of this group of optic neuropathies. In addition, because OPTN mutations are a contributing factor in patients with NPG, the gene may be a useful tool for presymptomatic screening of the general population. ation in cancer cells. PML-RAR is an oncogenic transcription factor found in acute promyelocytic leukemias (APLs) (4-6). Using PML-RAR as a paradigm for an oncoprotein, we examined whether PML-RAR is responsible for CpG methylation of its target genes and whether aberrant methylation is relevant for its biological activity. PML-RAR functions as a transcriptional regulator of retinoic acid (RA) target genes (7) (8) (9) . Among its putative targets, we focused on the RA receptor RAR␤2, because it contains a CpG island and is considered to be a putative tumor suppressor (10) .
Methyltransferase
Chromatin immunoprecipitation (ChIP) analysis of PR9 (U937 hemopoietic precursors carrying the PML-RAR cDNA under a zinc-inducible promoter) and control (MT) cells (11) revealed that PML-RAR is bound to the endogenous RAR␤2 promoter in vivo, irrespective of the presence of RA, its natural ligand (Fig. 1A) . Transient transfection of PML-RAR and an RAR␤2 promoter-luciferase reporter gene (RAR␤-Luc) (12) revealed a dose-dependent repressive effect of the fusion protein on RAR␤2 transcription (Fig. 1B) . Although RAR␤2 was expressed in untreated PR9 cells and normal hematopoietic precursors (CD34 ϩ ) (Fig. 1D) , it was not expressed in zinc-treated PR9 cells (as early as 8 hours after induction of PML-RAR expression) (Fig. 1C) , in blasts from four APL patients, or in the APL-derived NB4 cell line (Fig. 1D ). These findings indicate that PML-RAR binds to the RAR␤2 promoter and induces its transcriptional silencing.
To investigate RAR␤2 methylation in PML-RAR-expressing cells, we analyzed a CpG-rich region that comprises the RAR␤2 promoter and the 5Ј portion of the exon 1 by bisulfite sequencing, using eight randomly selected alleles from each APL sample type. In untreated PR9 cells, the frequency of 5-methylcytosine residues was approximately 9% (Fig. 1E, 0 hours) . Expression of PML-RAR induced further methylation of this region, which was evident as early as 4 to 8 hours (18 to 22%), and peaked at 48 hours (50%), after induction. Promoters that contain a CpG island but no RAR elements (RAREs) (such as that of p66shc) (13) were not modified by PML-RAR expression (14) . Comparable high frequencies of 5-methylcytosine residues were found in NB4 cells and in three APL samples (Fig. 1E) (15) . Methylation-specific polymerase chain reaction (PCR) (16) revealed methylation of the 5Ј portion of the RAR␤2 exon 1 in seven out of nine APL samples, but not in CD34 ϩ cells (15) . The minimum region of methylation found in all APL samples lies within the RAR␤2 exon 1, at one nucleosome distance from the RAR␤2 RARE and the TATA box (Fig. 1E) . Its methylation correlates with RAR␤2 silencing in breast cancers (17) .
We next investigated whether PML-RAR-induced methylation of RAR␤2 is responsible for its transcriptional silencing. In vitro methylation of the cloned RAR␤2 promoter, by either the Sss I or the Hpa II methylase, reduced its basal activity by about 85% (Fig. 1B) (14) . Only a single CpG-Hpa II methylation site is present within the iden- ϩ cells. (E) Methylation status of the RAR␤2 promoter. Genomic DNA from PR9, an APL patient, or NB4 cells were subjected to sodium bisulphite modification, and the RAR␤2 promoter was amplified as described (17) . To avoid differential amplification of methylated versus unmethylated CpGs, primers did not contain CpG dimers. Circles, CpG dinucleotides; green circles, Hpa II methylation sites; black and white squares, methylated and unmethylated CpGs, respectively. (F) Methylation-specific PCR of ectopically expressed RAR␤2 promoter. 293T cells were cotransfected with RAR␤-luc and PML-RAR or an empty vector. Recovered plasmids were subjected to sodium bisulphite treatment and amplified with primers specific for methylated (M) (RARb5Ј, 5-gtcgagaacgcgagcgattc-3; and LUC3Ј; 5-acgaataaaataacgccga-3) or unmethylated (U) (RARb5Ј, 5-gatgttgagattgtgagtgattt-3; and LUC3Ј; 5-acaaataaaataacaccaa-3) DNA.
tified common region of methylation (Fig.  1E) . PML-RAR-induced methylation of the cotransfected RAR␤2 promoter (Fig. 1F) and treatment with the methylation inhibitor 5-Aza-dC significantly reduced RAR␤2-luc repression by transfected PML-RAR (Fig.  1B) . Thus, DNA methylation contributes to the repressive effect of PML-RAR on RAR␤2 transcription.
We investigated whether PML-RAR associates with specific DNA methyltransferases, such as Dnmt1 or Dnmt3a (18, 19) . Coimmunoprecipitation experiments revealed a physical association between PML-RAR and endogenous Dnmt1 or Dnmt3a in both PR9 and NB4 cells (Fig. 2, A and B) . ChIP analysis of overexpressed proteins revealed that Dnmt1 and Dnmt3a were specifically enriched at the RAR␤2 promoter in the presence of PML-RAR (Fig. 2, C and D) , demonstrating that PML-RAR and Dnmt's form stable complexes on the RAR␤2 promoter.
PML-RAR expression disrupts the integrity of the PML nuclear bodies (NBs) and delocalizes several NB proteins to hundreds of punctated structures, so-called microspeckles (Fig. 2E) . In the absence of PML-RAR, both Dnmt1 and Dnmt3a are nuclear diffuse, whereas in cells expressing PML-RAR, Dnmt1 and Dnmt3a were delocalized to the PML-RAR microspeckles (Fig.  2E) (15) . Thus, PML-RAR expression alters the nuclear compartmentalization of Dnmt's and recruits them to the newly formed PML-RAR microspeckles.
We mapped the Dnmt3a binding sites within PML-RAR. Overexpressed Dnmt3a formed a stable complex with PML (Fig. 2F) but not with RAR (14) or RAR-RXR (Fig. 2G) . Because the PML moiety leads to oligomerization, we tested a chimeric protein containing RAR and the p53-tetramerization domain ( p53-RAR) (20) for interactions with Dnmt's. Dnmt3a interacted with p53-RAR (Fig. 2G) , 5) . Zn was washed out in lanes 3 and 5. Western blots of cell lysates were analyzed with the PGM3 antibody. (B and C) PR9 cells were untreated or treated with Zn, 5-Aza-dC, or a combination of these for 12 hours (B) or 48 hours (C). Zn was washed out from half the cells (washout), and cells were allowed to recover for 24 hours. VD (250 ng/ml) and transforming growth factor-␤ (1 ng/ml) were then added for 36 hours (black bars). Cell differentiation was monitored by flow cytometry of the differentiation antigen CD14, as previously described (4). Error bars represent the SD from the mean of triplicate experiments.
suggesting that RAR, in the context of the PML-RAR multimeric complex, contributes to the formation of PML-RAR/Dnmt complexes. PML-RAR, therefore, establishes multiple interactions with Dnmt's, through both its PML and RAR moieties.
We next asked whether the epigenetic modifications mediated by PML-RAR contribute to its biological activities. PML-RAR exerts opposing effects on differentiation: inhibitory, in the absence of RA; and stimulatory, in the presence of pharmacological doses of RA. Mechanistically, recruitment of the histone deacetylase (HDAC) complex by PML-RAR is critical for its ability to repress transcription and block differentiation (5) . Accordingly, RA treatment leads to dissociation of the PML-RAR/HDAC complex, conversion of PML-RAR into a transcriptional activator, and differentiation of APL blasts (5, 6) . Zinc treatment of PR9 cells for 12 or 48 hours blocked Vitamin D3-induced differentiation (Fig. 3B) . Removal of zinc from the culture medium (washout) led to the rapid disappearance of PML-RAR expression (within 24 hours) (Fig. 3A) . The PML-RAR-induced differentiation block could be reverted by zinc washout after a 12-hour, but not 48-hour, exposure to PML-RAR (Fig. 3C) . Differentiation block induced by transient (48 hours) exposure to PML-RAR was prevented by 5-Aza-dC (Fig. 3C) . Thus, transient PML-RAR expression suffices to induce epigenetic changes that render cells permanently refractory to differentiation. However, 5-Aza-dC treatment was unable to prevent the PML-RARinduced differentiation block when PML-RAR was continuously expressed (no washout) (Fig.  3C ). This suggests that PML-RAR represses transcription and blocks differentiation through two independent and temporally distinct mechanisms: (i) recruitment of HDAC (via the RAR moiety) (5, 6) , and (ii) recruitment of Dnmt's (through the PML moiety) and subsequent promoter methylation. This dual behavior is consistent with our observations that: (i) PML-RAR-induced repression of RAR␤2 transcription was only partially released by either 5-AzadC or the HDAC inhibitor trichostatin A (TSA) but was completely released by simultaneous treatment (Fig. 1B) ; (ii) RAR␤2 was silenced as early as 8 hours after PML-RAR expression, despite incomplete promoter methylation (Fig.  1, C and E) ; and (iii) RAR␤2 transcription was restored by TSA treatment at early (8 hours), but not late (48 hours), time points (Fig. 1C) . Similarly, in APL samples, RAR␤2 transcription was not induced by TSA alone but was induced by the combination of TSA, 5-Aza-dC, and RA (15) . A synergistic effect of TSA and 5-Aza-dC in restoring gene expression has been observed for other cancers (21) .
We investigated whether the RAR␤2 promoter is demethylated during RA-induced differentiation of APLs. In NB4 cells, treatment with RA and 5-Aza-dC decreased the frequency of 5-methylcytosine residues by approximately 50% when given individually and by 75% when given simultaneously (Fig.  4A) . Similar results were observed with blasts from three APL patients or with zincinduced PR9 cells (14, 15) . RA treatment led to an accumulation of RAR␤2 mRNA in both APL blasts and NB4 cells (Fig. 1D) . Cotreatment with RA and 5-Aza-dC led to a further increase in the RAR␤2 mRNA level, whereas 5-Aza-dC alone had no effect (Figs. 1D and 4B). These findings establish a tight correlation among RAR␤2 demethylation and reexpression and induction of differentiation (Fig. 4C) .
Our results suggest a scenario in which oncogenic transcription factors aberrantly recruit Dnmt's to target promoters. Newly methylated CpGs then become docking sites for methylbinding proteins, which in turn interact with both HDAC complexes and Dnmt's (22, 23) . The assembled complexes could be further stabilized by interactions between Dnmt's and HDAC1 (24, 25) . If the initial recruitment step is not prevented, it may eventually lead to spreading of hypermethylation to the neighboring regions, locking these into a stably silenced chromatin state. Fig. 1E . RA or 5-Aza-dC was added for 48 hours. (B) NB4 cells were untreated or treated for 48 hours with RA or 5-Aza-dC, as indicated. RT-PCR of RAR␤2 expression was performed as described in Fig. 1C . GAPDH, glyceraldehyde phosphate dehydrogenase. (C) Wright-Giemsa staining of blasts isolated from a newly diagnosed APL patient either untreated (i) or treated for 48 hours with RA (ii) or 5-Aza-dC (iii) or a combination of these (iv).
